NASDAQ: KZIA - Kazia Therapeutics Limited

六个月盈利: +4.5%
部门: Healthcare

促销时间表 Kazia Therapeutics Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Выручка 0
EBITDA -0.0073
Число акций ао 0.18428 млрд
P/S 13748.76
P/BV 1.52
EV/EBITDA -2.2
Цена ао 0.4286
ISIN US48669G1058
Сайт https://www.kaziatherapeutics.com
Див.доход ао 53.19
Дивиденд ао 6.05
Валюта usd
IPO date 1999-01-06
Sector Health Care
Industry Biotechnology
Валюта отчета aud
每日价格变化: +4.08% (0.4286)
每周价格变化: +13.17% (0.3942)
每月价格变化: +20.08% (0.3715)
3个月内价格变化: +132.34% (0.192)
六个月内的价格变化: +4.5% (0.4269)
每年价格变化: -53.04% (0.95)
3年内价格变化: -96.17% (11.64)
5年内价格变化: -81.17% (2.3696)
年初以来价格变化: -30.3% (0.64)
所有参数

低估

姓名 意义 年级
P/S 61225.34 1
P/BV 2.82 6
P/E 0 0
EV/EBITDA -1.37 0
全部的: 3.5

效率

姓名 意义 年级
ROA, % -72.87 0
ROE, % -169.83 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.75 7.5
全部的: 2.5

责任

姓名 意义 年级
Debt/EBITDA -0.0806 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -64.54 0
盈利能力 Ebitda, % 205.33 10
盈利能力 EPS, % 835.57 10
全部的: 7.8
更多详情

机构 体积 分享, %
Armistice Capital, LLC 2475555 10.47
Platinum Investment Management Ltd 1821887 7.71
Morgan Stanley 201550 0.85
Bank of Montreal/Can/ 140166 0.59
HSBC Holdings PLC 100194 0.42
TWO SIGMA SECURITIES, LLC 58423 0.25
XTX Topco Ltd 19436 0.08
Acadian Asset Management. LLC 18682 0.08
Citadel Advisors Llc 12809 0.05
BNP Paribas Financial Markets 12700 0.05



导师 职称 支付 出生年份
Ms. Anna Sandham Company Secretary N/A
Dr. John Edwin Friend II, M.D. CEO, MD & Director 731.09k 1970 (54 年)
Ms. Gabrielle Heaton BBUS (ACC), CPA Principal Accounting Officer, VP of Finance & Administration and Principal Financial Officer 178.56k

地址: Australia, Sydney, Three International Towers - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.kaziatherapeutics.com